Literature DB >> 7715380

A comparative diagnostic study of head and neck nodal metastases using positron emission tomography.

W F McGuirt1, D W Williams, J W Keyes, K M Greven, N E Watson, K R Geisinger, J O Cappellari.   

Abstract

A prospective study was conducted to compare the accuracy of clinical examination, computed tomography (CT), and positron emission tomography (PET) in identifying head and neck squamous cell carcinoma metastatic to cervical lymph nodes. The findings in the necks of 49 patients evaluated by clinical examination and CT were compared to the findings in the same necks by PET, a newly available metabolic imaging modality. Pathology specimens were available for 45 of the necks. The findings of PET and CT correlated in 84% of cases. In the cases that did not correlate, CT proved correct in four of five cases. PET (82%) and CT (84%) were comparable and were both better than clinical examination (71%) in correctly identifying the presence or absence of metastatic disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715380     DOI: 10.1288/00005537-199504000-00006

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  17 in total

1.  The accuracy of (18)[F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography, ultrasonography, and enhanced computed tomography alone in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma.

Authors:  Shinya Morita; Kenji Mizoguchi; Masanobu Suzuki; Keiji Iizuka
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

2.  Evaluation of the impact of addition of PET to CT and MR scanning in the staging of patients with head and neck carcinomas.

Authors:  Maky A Hafidh; Peter D Lacy; Joe P Hughes; George Duffy; Conrad V Timon
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-05-25       Impact factor: 2.503

Review 3.  Functional imaging in head and neck cancer.

Authors:  David I Kutler; Richard J Wong; Dennis H Kraus
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

4.  Assessment of clinical utility of 18F-FDG PET in patients with head and neck cancer: a probability analysis.

Authors:  Gerhard W Goerres; Katarzyna Mosna-Firlejczyk; Johann Steurer; Gustav K von Schulthess; Lucas M Bachmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-15       Impact factor: 9.236

5.  [18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods.

Authors:  S Dresel; J Grammerstorff; K Schwenzer; K Brinkbäumer; R Schmid; T Pfluger; K Hahn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-09       Impact factor: 9.236

6.  Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.

Authors:  Anthony Hannah; Andrew M Scott; Henri Tochon-Danguy; J Gordon Chan; Tim Akhurst; Salvatore Berlangieri; David Price; Gerard J Smith; Tony Schelleman; W J McKay; Andrew Sizeland
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

7.  [Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors].

Authors:  A N Rahn; R P Baum; I A Adamietz; S Adams; S Sengupta; S Mose; S B Bormeth; G Hör; H D Böttcher
Journal:  Strahlenther Onkol       Date:  1998-07       Impact factor: 3.621

Review 8.  Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.

Authors:  Hubert Vermeersch; David Loose; Hamphrey Ham; Andreas Otte; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-22       Impact factor: 9.236

Review 9.  The role of SPET and PET in monitoring tumour response to therapy.

Authors:  Chariklia Giannopoulou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-14       Impact factor: 9.236

10.  Value of sentinel lymph node biopsy in papillary thyroid cancer: initial results of a prospective trial.

Authors:  R N Cabrera; C T Chone; D Zantut-Wittmann; P Matos; D M Ferreira; P S G Pereira; R J R Ferrari; A O Santos; A N Crespo; E C S C Etchebehere
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-03       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.